MicroRNA-297b-5p/3p target Mllt3/Af9 to suppress lymphoma cell proliferation, migration and invasion in vitro and tumor growth in nude mice

References

• Schulze JM, Wang AY, Kobor MS. YEATS domain proteins: a diverse family with many links to chromatin modification and transcription. Biochem Cell Biol 2009;87:65–75.
   PubMed Web of Science ®Google Scholar
• Zeisig DT, Bittner CB, Zeisig BB, . The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene 2005;24:5525–5532.
   PubMed Web of Science ®Google Scholar
• Iida S, Seto M, Yamamoto K, . MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene 1993;8:3085–3092.
   PubMed Web of Science ®Google Scholar
• Pina C, May G, Soneji S, . MLLT3 regulates early human erythroid and megakaryocytic cell fate. Cell Stem Cell 2008;2:264–273.
   PubMed Web of Science ®Google Scholar
• Park G, Gong Z, Chen J, . Characterization of the DOT1L network: implications of diverse roles for DOT1L. Protein J 2010;29: 213–223.
   PubMed Web of Science ®Google Scholar
• Rubnitz JE, Morrissey J, Savage PA, . ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994;84:1747–1752.
   PubMed Web of Science ®Google Scholar
• Corral J, Lavenir I, Impey H, . An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 1996;85:853–861.
   PubMed Web of Science ®Google Scholar
• Hemenway CS, de Erkenez AC, Gould GC. The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t(9;11)(p22;q23) acute leukemias. Oncogene 2001;20:3798–3805.
   PubMed Web of Science ®Google Scholar
• Srinivasan RS, de Erkenez AC, Hemenway CS. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor. Oncogene 2003;22:3395–3406.
   PubMed Web of Science ®Google Scholar
• Vogel T, Gruss P. Expression of leukaemia associated transcription factor Af9/Mllt3 in the cerebral cortex of the mouse. Gene Expr Patterns 2009;9:83–93.
   PubMed Web of Science ®Google Scholar
• Buttner N, Johnsen SA, Kugler S, . Af9/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex. Proc Natl Acad Sci USA 2010;107:7042–7047.
   PubMed Web of Science ®Google Scholar
• Collins EC, Appert A, Ariza-McNaughton L, . Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia. Mol Cell Biol 2002;22:7313–7324.
   PubMed Web of Science ®Google Scholar
• Pramparo T, Grosso S, Messa J, . Loss-of-function mutation of the AF9/MLLT3 gene in a girl with neuromotor development delay, cerebellar ataxia, and epilepsy. Hum Genet 2005;118:76–81.
   PubMed Web of Science ®Google Scholar
• Huang W, Liu H, Wang T, . Tonicity-responsive microRNAs contribute to the maximal induction of osmoregulatory transcription factor OREBP in response to high-NaCl hypertonicity. Nucleic Acids Res 2011;39:475–485.
   PubMed Web of Science ®Google Scholar
• Zheng GX, Ravi A, Gould GM, . Genome-wide impact of a recently expanded microRNA cluster in mouse. Proc Natl Acad Sci USA 2011;108:15804–15809.
   PubMed Web of Science ®Google Scholar
• Neilson JR, Zheng GX, Burge CB, . Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 2007;21:578–589.
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008;18:131–140.
   PubMed Web of Science ®Google Scholar
• Zheng GX. Exploring the regulatory roles of microRNAs in mammalian development [Dissertation]. Boston: MIT; 2010.
   Google Scholar
• Wang K, Zhang S, Marzolf B, . Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009;106:4402–4407.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wu J, Wu SH, . Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat 2009;118:185–196.
   PubMed Web of Science ®Google Scholar
• Maes OC, An J, Sarojini H, . Murine microRNAs implicated in liver functions and aging process. Mech Ageing Dev 2008;129: 534–541.
   PubMedGoogle Scholar
• Fabbri M, Croce CM. Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol 2011;18:266–272.
   PubMed Web of Science ®Google Scholar
• Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma 2009;50:160–170.
   PubMed Web of Science ®Google Scholar
• Volinia S, Galasso M, Costinean S, . Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010;20: 589–599.
   PubMed Web of Science ®Google Scholar
• Li SC, Tang P, Lin WC. Intronic microRNA: discovery and biological implications. DNA Cell Biol 2007;26:195–207.
   PubMed Web of Science ®Google Scholar
• Jafarifar F, Yao P, Eswarappa SM, . Repression of VEGFA by CA-rich element-binding microRNAs is modulated by hnRNP L. EMBO J 2011;30:1324–1334.
   PubMedGoogle Scholar